SO vs STRO
Southern Company (SO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SO currently screens at market cap $101.55B and trailing P/E 22.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SO and STRO stock pages for the full models.
Not investment advice.